![Placing Novel, Fixed-Dose Dual Bronchodilators within the nice Guidelines for Chronic Obstructive Pulmonary Disease -Reflections on the Past, Present and Future Placing Novel, Fixed-Dose Dual Bronchodilators within the nice Guidelines for Chronic Obstructive Pulmonary Disease -Reflections on the Past, Present and Future](https://www.peertechzpublications.com/Pulmonology-Respiratory-Care/images/APRC-1-101-g001.gif)
Placing Novel, Fixed-Dose Dual Bronchodilators within the nice Guidelines for Chronic Obstructive Pulmonary Disease -Reflections on the Past, Present and Future
![Comparing LAMA with LABA and LTRA as add-on therapies in primary care asthma management | npj Primary Care Respiratory Medicine Comparing LAMA with LABA and LTRA as add-on therapies in primary care asthma management | npj Primary Care Respiratory Medicine](https://media.springernature.com/full/springer-static/image/art%3A10.1038%2Fs41533-020-00205-9/MediaObjects/41533_2020_205_Fig1_HTML.png)
Comparing LAMA with LABA and LTRA as add-on therapies in primary care asthma management | npj Primary Care Respiratory Medicine
![PDF] LAMA/LABA vs ICS/LABA in the treatment of COPD in Japan based on the disease phenotypes | Semantic Scholar PDF] LAMA/LABA vs ICS/LABA in the treatment of COPD in Japan based on the disease phenotypes | Semantic Scholar](https://d3i71xaburhd42.cloudfront.net/410388bf4ca6316b0fbca72a61ab191f5ae501af/7-Figure2-1.png)
PDF] LAMA/LABA vs ICS/LABA in the treatment of COPD in Japan based on the disease phenotypes | Semantic Scholar
![Comparative Effectiveness and Safety of Different Types of Inhaled Long-Acting β2-Agonist Plus Inhaled Long-Acting Muscarinic Antagonist vs Inhaled Long-Acting β2-Agonist Plus Inhaled Corticosteroid Fixed-Dose Combinations in COPD A Propensity Score ... Comparative Effectiveness and Safety of Different Types of Inhaled Long-Acting β2-Agonist Plus Inhaled Long-Acting Muscarinic Antagonist vs Inhaled Long-Acting β2-Agonist Plus Inhaled Corticosteroid Fixed-Dose Combinations in COPD A Propensity Score ...](https://ars.els-cdn.com/content/image/1-s2.0-S0012369221009521-fx1.jpg)
Comparative Effectiveness and Safety of Different Types of Inhaled Long-Acting β2-Agonist Plus Inhaled Long-Acting Muscarinic Antagonist vs Inhaled Long-Acting β2-Agonist Plus Inhaled Corticosteroid Fixed-Dose Combinations in COPD A Propensity Score ...
![Characteristics and treatment patterns of patients with asthma on multiple-inhaler triple therapy in Spain | npj Primary Care Respiratory Medicine Characteristics and treatment patterns of patients with asthma on multiple-inhaler triple therapy in Spain | npj Primary Care Respiratory Medicine](https://media.springernature.com/m685/springer-static/image/art%3A10.1038%2Fs41533-022-00270-2/MediaObjects/41533_2022_270_Fig1_HTML.png)
Characteristics and treatment patterns of patients with asthma on multiple-inhaler triple therapy in Spain | npj Primary Care Respiratory Medicine
![Comparative effectiveness of LABA-ICS versus LAMA as initial treatment in COPD targeted by blood eosinophils: a population-based cohort study - The Lancet Respiratory Medicine Comparative effectiveness of LABA-ICS versus LAMA as initial treatment in COPD targeted by blood eosinophils: a population-based cohort study - The Lancet Respiratory Medicine](https://www.thelancet.com/cms/attachment/cf7c63e7-298c-40aa-ace2-39bf59630ff1/gr1.gif)
Comparative effectiveness of LABA-ICS versus LAMA as initial treatment in COPD targeted by blood eosinophils: a population-based cohort study - The Lancet Respiratory Medicine
![Comparative Effectiveness and Safety of LABA-LAMA vs LABA-ICS Treatment of COPD in Real-World Clinical Practice - CHEST Comparative Effectiveness and Safety of LABA-LAMA vs LABA-ICS Treatment of COPD in Real-World Clinical Practice - CHEST](https://els-jbs-prod-cdn.jbs.elsevierhealth.com/cms/attachment/d931800b-8d46-45f8-9565-c86f8e6f1924/gr1_lrg.jpg)
Comparative Effectiveness and Safety of LABA-LAMA vs LABA-ICS Treatment of COPD in Real-World Clinical Practice - CHEST
![ICS/LABA Combined in One Inhaler vs LAMA Compared for Efficacy, Safety in COPD - Pulmonology Advisor ICS/LABA Combined in One Inhaler vs LAMA Compared for Efficacy, Safety in COPD - Pulmonology Advisor](https://www.pulmonologyadvisor.com/wp-content/uploads/sites/21/2019/01/asthmainhalersg613235634_1285202-860x573.jpg)
ICS/LABA Combined in One Inhaler vs LAMA Compared for Efficacy, Safety in COPD - Pulmonology Advisor
![Trelegy Ellipta is the first triple inhaler in the US, featuring a LAMA /LABA/ICS combination. Though it was FDA approved 1 full … | Inhaler, Ambulatory care, Labas Trelegy Ellipta is the first triple inhaler in the US, featuring a LAMA /LABA/ICS combination. Though it was FDA approved 1 full … | Inhaler, Ambulatory care, Labas](https://i.pinimg.com/originals/5e/3c/86/5e3c8631532e41f3d6120138f2f80739.jpg)
Trelegy Ellipta is the first triple inhaler in the US, featuring a LAMA /LABA/ICS combination. Though it was FDA approved 1 full … | Inhaler, Ambulatory care, Labas
![Effectiveness of Treatment With Dual Bronchodilation (LABA/LAMA) Compared With Combination Therapy (LABA/ICS) for Patients With COPD: A Population-Based Study - ScienceDirect Effectiveness of Treatment With Dual Bronchodilation (LABA/LAMA) Compared With Combination Therapy (LABA/ICS) for Patients With COPD: A Population-Based Study - ScienceDirect](https://ars.els-cdn.com/content/image/1-s2.0-S0300289622003374-gr1.jpg)
Effectiveness of Treatment With Dual Bronchodilation (LABA/LAMA) Compared With Combination Therapy (LABA/ICS) for Patients With COPD: A Population-Based Study - ScienceDirect
![JPM | Free Full-Text | Escalation Time to Open Triple Combination Therapy from the Initiation of LAMA versus ICS/LABA in COPD Management: Findings from Comparing the Incidence of Tiotropium and ICS/LABA in JPM | Free Full-Text | Escalation Time to Open Triple Combination Therapy from the Initiation of LAMA versus ICS/LABA in COPD Management: Findings from Comparing the Incidence of Tiotropium and ICS/LABA in](https://www.mdpi.com/jpm/jpm-11-01325/article_deploy/html/images/jpm-11-01325-g003.png)
JPM | Free Full-Text | Escalation Time to Open Triple Combination Therapy from the Initiation of LAMA versus ICS/LABA in COPD Management: Findings from Comparing the Incidence of Tiotropium and ICS/LABA in
![Clinical characteristics and medication patterns in patients with COPD prior to initiation of triple therapy with ICS/LAMA/LABA: A retrospective study - Respiratory Medicine Clinical characteristics and medication patterns in patients with COPD prior to initiation of triple therapy with ICS/LAMA/LABA: A retrospective study - Respiratory Medicine](https://els-jbs-prod-cdn.jbs.elsevierhealth.com/cms/attachment/b7e10cce-3c54-420b-9145-18786f8e51bc/gr1.jpg)